Automation & Drives India: Advancing Through Robotic Automation
Market forces are changing the pharmaceutical industry and forcing manufacturers to adopt more flexible methods of production. The article details how India’s pharmaceutical industry is advancing through robotic automation within a gloveless isolator for the production of sterile injectables.
New pharmaceutical products are complex, high-value and hard to manufacture. Drug discovery platforms are creating more clinical drug candidates. These new therapies are targeted at smaller patient populations. As patents for top-selling biological medicines lapse, the market for generic biosimilars is rapidly growing. Many of these drugs are injectables that need to be aseptically produced in different vial, syringe and cartridge containers.
All of these conditions call for increased flexibility. With India as a centre for generic and biosimilar drug production, its pharmaceutical industry stands to accelerate its growth by adopting advances in standardisation and flexibility. Adopting new technologies will help to bring drug products to market faster and grow market share and profitability.
Read the full article by John Harmer, Technical Sales Director: Automation & Drives India – Advancing Through Robotic Automation (PDF)